Company profile
Passage BIO, Inc. Insider Trading
PASGEvery SEC Form 4 insider trading filing for Passage BIO, Inc. (PASG) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001787297
- Filings
- 73
- Insiders
- 19
- Last filing
- 2026-06-25
Activity summary
No insider transactions in the last 30 days. The most recent was on June 25, 2026, when Lynx1 Capital Management LP bought 50,055 shares. 73 filings from 19 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Passage BIO, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $958K.
90 day insight
Over the last 90 days, Passage BIO, Inc. insiders bought $206K across 1 transaction with no open-market sales.
- Most active insider: Lynx1 Capital Management LP with 1 transaction totaling $206K.
- Largest single purchase: $206K by Lynx1 Capital Management LP on Jun 25, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Lynx1 Capital Management LP | PASG | Purchase | 50,055 | $4.12 | $206K |
| May 19, 2026 | Athena Countouriotis | PASG | Award | 10,539 | — | — |
| May 19, 2026 | Maxine Gowen | PASG | Award | 10,539 | — | — |
| May 19, 2026 | Sandip Kapadia | PASG | Award | 10,539 | — | — |
| May 19, 2026 | Thomas Richard Kassberg | PASG | Award | 10,539 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=PASG" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Passage BIO, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →